DENTSPLY SIRONA Inc. (XRAY)
USD 12.66
(-4.38%)
USD 12.66
(-4.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.96 Billion USD | 13.72% |
| 2022 | 1.72 Billion USD | -9.1% |
| 2021 | 1.9 Billion USD | -3.45% |
| 2020 | 1.96 Billion USD | 71.22% |
| 2019 | 1.15 Billion USD | -14.67% |
| 2018 | 1.34 Billion USD | 4.39% |
| 2017 | 1.29 Billion USD | 14.53% |
| 2016 | 1.12 Billion USD | 31.62% |
| 2015 | 856.4 Million USD | -14.47% |
| 2014 | 1 Billion USD | -8.25% |
| 2013 | 1.09 Billion USD | -4.44% |
| 2012 | 1.14 Billion USD | -19.18% |
| 2011 | 1.41 Billion USD | 2108.42% |
| 2010 | 63.97 Million USD | 201.23% |
| 2009 | -63.19 Million USD | -125.74% |
| 2008 | 245.48 Million USD | -21.8% |
| 2007 | 313.92 Million USD | 2.89% |
| 2006 | 305.09 Million USD | 23.12% |
| 2005 | 247.79 Million USD | -28.48% |
| 2004 | 346.45 Million USD | -46.57% |
| 2003 | 648.42 Million USD | -13.4% |
| 2002 | 748.72 Million USD | 7.35% |
| 2001 | 697.44 Million USD | 635.23% |
| 2000 | 94.86 Million USD | -40.04% |
| 1999 | 158.2 Million USD | -29.72% |
| 1998 | 225.1 Million USD | 88.05% |
| 1997 | 119.7 Million USD | 24.43% |
| 1996 | 96.2 Million USD | 33.06% |
| 1995 | 72.3 Million USD | 395.21% |
| 1994 | 14.6 Million USD | -86.25% |
| 1993 | 106.2 Million USD | 1211.11% |
| 1992 | 8.1 Million USD | -73.95% |
| 1991 | 31.1 Million USD | 455.36% |
| 1990 | 5.6 Million USD | 609.09% |
| 1989 | -1.1 Million USD | -266.67% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.91 Billion USD | -2.34% |
| 2024 Q2 | 1.93 Billion USD | 0.73% |
| 2023 Q3 | 1.81 Billion USD | -7.02% |
| 2023 Q4 | 1.96 Billion USD | 8.32% |
| 2023 Q1 | 1.98 Billion USD | 14.81% |
| 2023 Q2 | 1.95 Billion USD | -1.66% |
| 2023 FY | 1.96 Billion USD | 13.72% |
| 2022 Q4 | 1.72 Billion USD | 0.52% |
| 2022 Q1 | 2 Billion USD | 5.31% |
| 2022 Q3 | 1.71 Billion USD | -5.76% |
| 2022 Q2 | 1.82 Billion USD | -8.89% |
| 2022 FY | 1.72 Billion USD | -9.1% |
| 2021 Q1 | 2.05 Billion USD | 4.52% |
| 2021 Q4 | 1.9 Billion USD | -1.71% |
| 2021 Q3 | 1.93 Billion USD | -6.03% |
| 2021 FY | 1.9 Billion USD | -3.45% |
| 2021 Q2 | 2.05 Billion USD | 0.0% |
| 2020 Q2 | 1.17 Billion USD | -11.44% |
| 2020 Q3 | 1.05 Billion USD | -9.82% |
| 2020 Q4 | 1.96 Billion USD | 85.84% |
| 2020 FY | 1.96 Billion USD | 71.22% |
| 2020 Q1 | 1.32 Billion USD | 15.36% |
| 2019 FY | 1.15 Billion USD | -14.67% |
| 2019 Q4 | 1.15 Billion USD | -12.08% |
| 2019 Q2 | 1.36 Billion USD | -6.76% |
| 2019 Q3 | 1.3 Billion USD | -4.3% |
| 2019 Q1 | 1.46 Billion USD | 8.77% |
| 2018 Q3 | 1.49 Billion USD | -4.4% |
| 2018 Q2 | 1.56 Billion USD | 17.84% |
| 2018 Q1 | 1.32 Billion USD | 2.9% |
| 2018 Q4 | 1.34 Billion USD | -9.94% |
| 2018 FY | 1.34 Billion USD | 4.39% |
| 2017 Q1 | 1.16 Billion USD | 3.34% |
| 2017 FY | 1.29 Billion USD | 14.53% |
| 2017 Q4 | 1.29 Billion USD | 4.9% |
| 2017 Q3 | 1.23 Billion USD | -8.19% |
| 2017 Q2 | 1.34 Billion USD | 15.08% |
| 2016 Q4 | 1.12 Billion USD | -10.22% |
| 2016 Q3 | 1.25 Billion USD | 45.95% |
| 2016 Q1 | 846 Million USD | -1.21% |
| 2016 FY | 1.12 Billion USD | 31.62% |
| 2016 Q2 | 860.2 Million USD | 1.68% |
| 2015 Q2 | 981.3 Million USD | 0.32% |
| 2015 Q1 | 978.2 Million USD | -2.3% |
| 2015 FY | 856.4 Million USD | -14.47% |
| 2015 Q4 | 856.4 Million USD | 83.97% |
| 2015 Q3 | 465.5 Million USD | -52.56% |
| 2014 Q1 | 1.41 Billion USD | 29.47% |
| 2014 Q3 | 1.18 Billion USD | -9.0% |
| 2014 FY | 1 Billion USD | -8.25% |
| 2014 Q4 | 1 Billion USD | -15.38% |
| 2014 Q2 | 1.3 Billion USD | -7.97% |
| 2013 Q4 | 1.09 Billion USD | -21.22% |
| 2013 Q1 | 1.46 Billion USD | 28.47% |
| 2013 Q2 | 1.48 Billion USD | 1.15% |
| 2013 Q3 | 1.38 Billion USD | -6.65% |
| 2013 FY | 1.09 Billion USD | -4.44% |
| 2012 FY | 1.14 Billion USD | -19.18% |
| 2012 Q1 | 1.41 Billion USD | -16.32% |
| 2012 Q2 | 1.67 Billion USD | 18.21% |
| 2012 Q3 | 1.59 Billion USD | -4.69% |
| 2012 Q4 | 1.14 Billion USD | -28.32% |
| 2011 FY | 1.41 Billion USD | 2108.42% |
| 2011 Q4 | 1.68 Billion USD | -1.32% |
| 2011 Q3 | 1.71 Billion USD | 20636.32% |
| 2011 Q2 | -8.33 Million USD | -109.42% |
| 2011 Q1 | 88.47 Million USD | 23.35% |
| 2010 Q3 | 65.42 Million USD | -51.38% |
| 2010 Q2 | 134.55 Million USD | 88.21% |
| 2010 FY | 63.97 Million USD | 201.23% |
| 2010 Q4 | 71.73 Million USD | 9.64% |
| 2010 Q1 | 71.49 Million USD | 276.74% |
| 2009 Q1 | 260.16 Million USD | 5.98% |
| 2009 Q3 | -178.52 Million USD | -68.54% |
| 2009 Q4 | 18.97 Million USD | 110.63% |
| 2009 FY | -63.19 Million USD | -125.74% |
| 2009 Q2 | -105.92 Million USD | -140.71% |
| 2008 Q2 | 468.04 Million USD | -6.76% |
| 2008 Q3 | 350.3 Million USD | -25.16% |
| 2008 Q4 | 245.48 Million USD | -29.92% |
| 2008 FY | 245.48 Million USD | -21.8% |
| 2008 Q1 | 501.97 Million USD | 59.9% |
| 2007 FY | 313.92 Million USD | 2.89% |
| 2007 Q1 | 319.03 Million USD | 4.57% |
| 2007 Q2 | 332.79 Million USD | 4.31% |
| 2007 Q4 | 313.92 Million USD | -13.01% |
| 2007 Q3 | 360.86 Million USD | 8.44% |
| 2006 Q1 | 251.92 Million USD | 1.67% |
| 2006 Q2 | 326.6 Million USD | 29.64% |
| 2006 Q3 | 440.49 Million USD | 34.87% |
| 2006 Q4 | 305.09 Million USD | -30.74% |
| 2006 FY | 305.09 Million USD | 23.12% |
| 2005 Q1 | 333.93 Million USD | -3.61% |
| 2005 FY | 247.79 Million USD | -28.48% |
| 2005 Q3 | 352.29 Million USD | -2.6% |
| 2005 Q4 | 247.79 Million USD | -29.66% |
| 2005 Q2 | 361.68 Million USD | 8.31% |
| 2004 FY | 346.45 Million USD | -46.57% |
| 2004 Q1 | 522.52 Million USD | -19.42% |
| 2004 Q2 | 450.26 Million USD | -13.83% |
| 2004 Q3 | 397.08 Million USD | -11.81% |
| 2004 Q4 | 346.45 Million USD | -12.75% |
| 2003 FY | 648.42 Million USD | -13.4% |
| 2003 Q4 | 648.42 Million USD | -9.32% |
| 2003 Q3 | 715.07 Million USD | -4.52% |
| 2003 Q2 | 748.93 Million USD | -0.92% |
| 2003 Q1 | 755.87 Million USD | 0.95% |
| 2002 Q2 | 778.34 Million USD | 8.56% |
| 2002 FY | 748.72 Million USD | 7.35% |
| 2002 Q1 | 716.95 Million USD | 2.8% |
| 2002 Q4 | 748.72 Million USD | -1.06% |
| 2002 Q3 | 756.75 Million USD | -2.77% |
| 2001 Q3 | 332.32 Million USD | 2.37% |
| 2001 Q1 | 258.28 Million USD | 172.28% |
| 2001 FY | 697.44 Million USD | 635.23% |
| 2001 Q2 | 324.63 Million USD | 25.69% |
| 2001 Q4 | 697.44 Million USD | 109.87% |
| 2000 Q4 | 94.86 Million USD | -19.64% |
| 2000 Q2 | 134.91 Million USD | -6.98% |
| 2000 Q1 | 145.02 Million USD | -8.33% |
| 2000 FY | 94.86 Million USD | -40.04% |
| 2000 Q3 | 118.04 Million USD | -12.5% |
| 1999 FY | 158.2 Million USD | -29.72% |
| 1999 Q3 | 184.8 Million USD | -12.17% |
| 1999 Q4 | 158.2 Million USD | -14.39% |
| 1999 Q1 | 223.5 Million USD | -0.71% |
| 1999 Q2 | 210.4 Million USD | -5.86% |
| 1998 Q2 | 202.2 Million USD | 44.95% |
| 1998 Q4 | 225.1 Million USD | 13.17% |
| 1998 Q3 | 198.9 Million USD | -1.63% |
| 1998 Q1 | 139.5 Million USD | 16.54% |
| 1998 FY | 225.1 Million USD | 88.05% |
| 1997 FY | 119.7 Million USD | 24.43% |
| 1997 Q1 | 154.9 Million USD | 61.02% |
| 1997 Q2 | 139.5 Million USD | -9.94% |
| 1997 Q3 | 136.1 Million USD | -2.44% |
| 1997 Q4 | 119.7 Million USD | -12.05% |
| 1996 Q1 | 128.4 Million USD | 77.59% |
| 1996 FY | 96.2 Million USD | 33.06% |
| 1996 Q2 | 114.9 Million USD | -10.51% |
| 1996 Q3 | 110.4 Million USD | -3.92% |
| 1996 Q4 | 96.2 Million USD | -12.86% |
| 1995 Q3 | 98.8 Million USD | -11.07% |
| 1995 Q2 | 111.1 Million USD | 91.22% |
| 1995 FY | 72.3 Million USD | 395.21% |
| 1995 Q4 | 72.3 Million USD | -26.82% |
| 1995 Q1 | 58.1 Million USD | 297.95% |
| 1994 FY | 14.6 Million USD | -86.25% |
| 1994 Q1 | 100.2 Million USD | -5.65% |
| 1994 Q2 | 83.2 Million USD | -16.97% |
| 1994 Q3 | 68.9 Million USD | -17.19% |
| 1994 Q4 | 14.6 Million USD | -78.81% |
| 1993 Q3 | 217.8 Million USD | -4.72% |
| 1993 FY | 106.2 Million USD | 1211.11% |
| 1993 Q1 | 12.4 Million USD | -26.19% |
| 1993 Q2 | 228.6 Million USD | 1743.55% |
| 1993 Q4 | 106.2 Million USD | -51.24% |
| 1992 Q2 | 4.7 Million USD | -41.98% |
| 1992 Q3 | 11.8 Million USD | 151.06% |
| 1992 Q1 | 8.1 Million USD | 1925.0% |
| 1992 FY | 8.1 Million USD | -73.95% |
| 1992 Q4 | 16.8 Million USD | 42.37% |
| 1991 Q2 | 30 Million USD | -3.54% |
| 1991 FY | 31.1 Million USD | 455.36% |
| 1991 Q3 | 24 Million USD | -20.0% |
| 1991 Q4 | 400 Thousand USD | -98.33% |
| 1991 Q1 | 31.1 Million USD | -22.06% |
| 1990 Q1 | 5.6 Million USD | -15.15% |
| 1990 FY | 5.6 Million USD | 609.09% |
| 1990 Q2 | -2.1 Million USD | -137.5% |
| 1990 Q3 | 38.7 Million USD | 1942.86% |
| 1990 Q4 | 39.9 Million USD | 3.1% |
| 1989 Q1 | -1.1 Million USD | 0.0% |
| 1989 FY | -1.1 Million USD | -266.67% |
| 1989 Q3 | 6.9 Million USD | -1.43% |
| 1989 Q2 | 7 Million USD | 736.36% |
| 1989 Q4 | 6.6 Million USD | -4.35% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -76033.282% |
| AngioDynamics, Inc. | -70.14 Million USD | 2901.46% |
| AtriCure, Inc. | -9.81 Million USD | 20118.337% |
| Avinger, Inc. | 10.12 Million USD | -19316.996% |
| Azenta, Inc. | -618.47 Million USD | 417.717% |
| BioLife Solutions, Inc. | 7.25 Million USD | -26992.238% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 19.744% |
| Daxor Corporation | 755.65 Thousand USD | -259937.927% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 133773.469% |
| Femasys Inc. | -15.01 Million USD | 13186.743% |
| GlucoTrack, Inc. | -4.29 Million USD | 45840.223% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -5005.222% |
| Hologic, Inc. | 374.4 Million USD | -424.84% |
| ICU Medical, Inc. | 1.45 Billion USD | -35.471% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 173.864% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 28023.355% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 38078.353% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 45931.47% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 45931.47% |
| Masimo Corporation | 804 Million USD | -144.403% |
| Microbot Medical Inc. | -2.28 Million USD | 86058.005% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 20577.829% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -550.182% |
| Nephros, Inc. | -2.47 Million USD | 79622.461% |
| NovoCure Limited | 355.42 Million USD | -452.865% |
| NEXGEL, Inc. | 98 Thousand USD | -2005002.041% |
| NEXGEL, Inc. | 98 Thousand USD | -2005002.041% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -3227.407% |
| OraSure Technologies, Inc. | -276.9 Million USD | 809.635% |
| Pro-Dex, Inc. | 10.91 Million USD | -17901.099% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 5679.058% |
| Predictive Oncology Inc. | -5.87 Million USD | 33564.774% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -64768.976% |
| QuidelOrtho Corporation | 2.49 Billion USD | 21.249% |
| Repligen Corporation | -39.51 Million USD | 5072.292% |
| Sanara MedTech Inc. | 6.64 Million USD | -29471.578% |
| STAAR Surgical Company | -147.2 Million USD | 1434.882% |
| Sharps Technology, Inc. | -3.01 Million USD | 65319.383% |
| Utah Medical Products, Inc. | -92.52 Million USD | 2223.727% |
| Jin Medical International Ltd. | -2.81 Million USD | 69867.244% |